Videos

Who Is Most at Risk for Secondary Interventions for Type B Dissections?

02/12/2020

John Fritz Angle, MD, describes how to handle the medical emergency of a type B dissection and which patients might need additional interventions.

Stay in the Know

Vascular Disease Management Newsletter

News

Echo IQ Signs Integration Agreement With Flagship US Hospital

12/12/2024

Integration agreement secured with Beth Israel Deaconess Medical Center, Boston USA ▪  Integration follows successful trial of EchoSolv-AS by Beth Israel researchers on a historical cohort of 31,000 patients  ▪  Trial...

Integration agreement secured...

12/12/2024

Vascular Disease Management

Radial to Peripheral

Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter

12/03/2024

“With the 200 cm length, the R2P NaviCross catheter provides physicians performing percutaneous transluminal endovascular procedures from the radial artery a valuable tool to enhance their ability to safely and efficiently complete more...

“With the 200 cm length, the R2P...

12/03/2024

Cath Lab Digest

Bridging Stent for FEVAR

World premiere for Bentley’s BeFlared Bridging Stent: Successful “First in Man” Operation

12/02/2024

Hechingen, November 26th, 2024 -- Shortly after receiving the CE certification for its BeFlared Stent Graft System, the world’s first dedicated bridging stent for fenestrated endovascular aneurysm repair (FEVAR), Bentley announced the...

Hechingen, November 26th, 2024...

12/02/2024

Vascular Disease Management

News

Fluidx Medical Announces First Tumor Patient Treated in Prospective, Multinational Trial

11/27/2024

Embolic device designed for improved preparation, delivery, and deep vessel filling for treating tumors and other interventional oncology uses.  Salt Lake City (UT) – Fluidx Medical Technology, Inc. announced today that the first...

Embolic device designed for...

11/27/2024

Vascular Disease Management

News

CIS & IMC Are First in Acadiana to Use New Dissolvable Esprit™ System to Treat Artery Disease Below the Knee

11/25/2024

NEW IBERIA, LA – Cardiovascular Institute of the South (CIS) and Iberia Medical Center (IMC) are the first in Acadiana to use the new FDA-approved Esprit™ BTK (Below the Knee) Everolimus Eluting Resorbable Scaffold System, a first-of-its-kind...

NEW IBERIA, LA – Cardiovascular...

11/25/2024

Vascular Disease Management

News

Double Win With Bridging Stents: FEVAR Certifications for BeGraft and BeFlared

11/20/2024

Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...

Hechingen, November 20th, 2024....

11/20/2024

Vascular Disease Management

First Aid guidelines

AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies

11/14/2024

These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.

These are the first major...

11/14/2024

Cath Lab Digest

Late-Breaking Trials

Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/06/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...

The VIVA Foundation, a...

11/06/2024

Vascular Disease Management

Late-Breaking Trials

Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/05/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...

The VIVA Foundation, a...

11/05/2024

Vascular Disease Management

Late-Breaking Trials

Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/04/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...

The VIVA Foundation, a...

11/04/2024

Vascular Disease Management

Who Is Most at Risk for Secondary Interventions for Type B Dissections?

Stay in the Know

News

Specialties

Events

Year Round Education

HMP Global Products